美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Medicus Pharma Ltd.

2.48

-0.0250-1.00%

成交量：4.60万

成交额：11.38万

市值：3,943.53万

市盈率：- -

高：2.50

开：2.45

低：2.44

收：2.50

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

Scynexis, Inc.盘中异动股价大涨8.06%报1.010美元

Medicus Pharma Ltd.2025财年第一财季实现净利润-5.10百万美元，同比减少184.92%

D. Boral Capital：维持Medicus Pharma评级，由买入调整至买入评级, 目标价由14.00美元调整至27.00美元。

Maxim Group：维持Medicus Pharma评级，由买入调整至买入评级, 目标价由10.00美元调整至20.00美元。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/MDCX"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":2.475,"timestamp":1753972103932,"preClose":2.5,"halted":0,"volume":46031,"delay":0,"floatShares":6964800,"shares":15933444,"eps":0,"marketStatus":"交易中","change":-0.025,"latestTime":"07-31 10:31:24 EDT","open":2.45,"high":2.5,"low":2.44,"amount":113778.7721598,"amplitude":0.024,"askPrice":2.5,"askSize":2206,"bidPrice":2.43,"bidSize":215,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1753992000000},"marketStatusCode":2,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":2.5,"preHourTrading":{"tag":"盘前","latestPrice":2.43,"preClose":2.5,"latestTime":"09:06 EDT","volume":351,"amount":850.4595567,"timestamp":1753967199810},"postHourTrading":{"tag":"盘后","latestPrice":2.4201,"preClose":2.5,"latestTime":"19:50 EDT","volume":6400,"amount":15589.8741,"timestamp":1753919409501},"volumeRatio":0.717383},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":6964800,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.717383,"shares":15933444,"dividePrice":0,"high":2.5,"amplitude":0.024,"preClose":2.5,"low":2.44,"week52Low":1.8,"pbRate":"--","week52High":8.94,"institutionHeld":0,"latestPrice":2.475,"committee":-0.822387,"eps":0,"divideRate":0,"volume":46031,"delay":0,"ttmEps":0,"open":2.45,"prevYearClose":2.43,"prevWeekClose":2.93,"prevMonthClose":2.99,"prevQuarterClose":2.99,"fiveDayClose":3.02,"twentyDayClose":3.22,"sixtyDayClose":4.27},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MDCX\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2539658072","title":"Scynexis, Inc.盘中异动 股价大涨8.06%报1.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539658072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539658072?lang=zh_cn&edition=fundamental","pubTime":"2025-05-29 21:31","pubTimestamp":1748525477,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日21时31分，Scynexis, Inc.股票出现波动，股价急速上涨8.06%。截至发稿，该股报1.010美元/股，成交量8.1099万股，换手率0.21%，振幅1.07%。Scynexis, Inc.股票所在的制药行业中，整体跌幅为0.13%。Scynexis, Inc.公司简介：SCYNEXIS Inc 是一家药物开发公司，专注于开发和商业化新型抗感染药物，以满足未被满足的治疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529213117a4916bcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529213117a4916bcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","MDCX","SCYX"],"gpt_icon":0},{"id":"2536591024","title":"Medicus Pharma Ltd.2025财年第一财季实现净利润-5.10百万美元，同比减少184.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536591024","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536591024?lang=zh_cn&edition=fundamental","pubTime":"2025-05-19 00:01","pubTimestamp":1747584080,"startTime":"0","endTime":"0","summary":"5月19日，Medicus Pharma Ltd.公布财报，公告显示公司2025财年第一财季净利润为-5.10百万美元，同比减少184.92%；其中营业收入为0.00美元，每股基本收益为-0.42美元。从资产负债表来看，Medicus Pharma Ltd.总负债3.51百万美元，其中短期债务120296.00美元，资产负债比为1.62，流动比率为1.53。机构评级：截至2025年5月19日，当前有3家机构对Medicus Pharma Ltd.目标价做出预测，其中目标均价为19.67美元，其中最低目标价为12.00美元，最高目标价为27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000444a482f10b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000444a482f10b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDCX"],"gpt_icon":0},{"id":"2534220570","title":"D. Boral Capital：维持Medicus Pharma评级，由买入调整至买入评级, 目标价由14.00美元调整至27.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534220570","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534220570?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 19:21","pubTimestamp":1747048905,"startTime":"0","endTime":"0","summary":"D. Boral Capital：维持Medicus Pharma(MDCX.US)评级，由买入调整至买入评级, 目标价由14.00美元调整至27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051219512694f46bc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051219512694f46bc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDCX"],"gpt_icon":0},{"id":"2534157055","title":"Maxim Group：维持Medicus Pharma评级，由买入调整至买入评级, 目标价由10.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534157055","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534157055?lang=zh_cn&edition=fundamental","pubTime":"2025-05-09 02:01","pubTimestamp":1746727274,"startTime":"0","endTime":"0","summary":"Maxim Group：维持Medicus Pharma(MDCX.US)评级，由买入调整至买入评级, 目标价由10.00美元调整至20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050902081997537d8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050902081997537d8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDCX"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1744689600000}}}